Treatment with inhaled steroids in patients with symptoms suggestive of asthma but with normal lung function

European Respiratory Journal

Volumn 32, Issue 4, 2008, Pages 989-996

  Rytila P ^a   Ghaly, L ^b   Varghese, S ^b   Chung, W ^b   Selroos, O ^c   Haahtela, T ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Semeco AB ^*  (Sweden)

Author keywords

Airway inflammation; Asthma symptoms; Induced sputum; Mometasone furoate; Placebo

Indexed keywords

ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CATION; CORTICOSTEROID; EOSINOPHIL CATIONIC PROTEIN; MOMETASONE FUROATE; PLACEBO; SALBUTAMOL;

ADULT; AGED; ARTICLE; ASTHMA; CHEST TIGHTNESS; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DYSPNEA; EOSINOPHIL; EVENING DOSAGE; EXERCISE INDUCED ASTHMA; FEMALE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; WHEEZING;

ADMINISTRATION, INHALATION; ADULT; AGED; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PLACEBOS; PREGNADIENEDIOLS; STEROIDS; TREATMENT OUTCOME;

EID: 58849090523     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00062307     Document Type: Article

References (33)

1. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993; 147: 697-704.
2. Vignola AM, Chanez P, Campbell AM, et al. Airway inflammation in mild intermittent and persistent asthma. Am J Respir Crit Care Med 1998; 157: 403-409.
3. National Institutes of Health, National Heart, Lung and Blood Institute. NHLBI/WHO Workshop report. Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma, 2007. Available from: www.ginasthma.com.
4. Hargreave FE, Ryan G, Thomson NC, et al. Bronchial responsiveness to histamine methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol 1981; 68: 347-355.
5. Rytilä P, Metso T, Petäys T, et al. Eosinophilic airway inflammation as an underlying mechanism of undiagnosed prolonged cough in primary health-care patients. Respir Med 2002; 96: 52-58.
6. Pizzichini E, Pizzichini MMM, Efthimiadis A, Dolovich J, Hargreave FE. Measuring airway inflammation in asthma: eosinophils and eosinophil cationic protein in induced sputum compared with peripheral blood. J Allergy Clin Immunol 1997; 99: 539-544.
7. Sorva R, Metso T, Turpeinen M, Juntunen-Backman K, Björkstén F, Haahtela T. Eosinophil cationic protein in induced sputum as a marker of inflammation in asthmatic children. Pediatr Allergy Immunol 1997; 8: 45-50.
8. Kharitonov SA, Barnes PJ. Does exhaled nitric oxide reflect asthma control? Yes, it does! Am J Respir Crit Care Med 2001; 164: 727-728.
9. Dodge RR, Burrows B. The prevalence and incidence of asthma and asthma-like symptoms in a general population sample. Am Rev Respir Dis 1980; 122: 567-575.
10. Haahtela T, Laitinen LA. Asthma programme in Finland 1994-2004. Clin Exp Allergy 1996; 26: Suppl. 1, 1-24.
11. Haahtela T. Early treatment of asthma. Allergy 1999; 54: Suppl. 49, 74-81.
12. Haahtela T. Eosinophilic bronchial inflammation. Early intervention with inhaled corticosteroids. Allergy Clin Immunol News 2004; 16: 4-8.
13. Rytilä P, Metso T, Heikkinen K, Saarelainen P, Helenius IJ, Haahtela T. Airway inflammation in patients with symptoms suggesting asthma but with normal lung function. Eur Respir J 2000; 16: 824-830.
14. Brightling CE, Ward R, Goh KL, Wardlaw AJ, Pavord ID. Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med 1999; 160: 406-410.
15. Gibson PG Dolovich J, Denburg J, Ramsdale EH, Hargreave FE. Chronic cough: eosinophilic inflammation without asthma. Lancet 1989; 1: 1346-1348.
16. Panhuysen CI, Vonk JM, Koeter GH, et al. Adult patients may outgrow their asthma. A 25-year follow-up study. Am J Respir Crit Care Med 1997; 155: 1267-1272.
17. Sovijärvi ARA, Malmberg P, Reinikainen K, Rytilä P, Poppius H. A rapid dosimetric method with controlled tidal breathing for histamine challenge. Chest 1993; 104: 164-170.
18. Nieminen MM. Unimodal distribution of bronchial hyper-responsiveness to methacholine in asthmatic patients. Chest 1992; 102: 1537-1543.
19. Remes ST, Korppi M, Remes K. Outcome of children with respiratory symptoms without objective evidence of asthma: a two-year, prospective, follow-up study. Acta Paediatr 1998; 87: 165-168.
20. Glauser FL. Variant asthma. Ann Allergy 1972; 30: 457-459.
21. McFadden ER Jr. Extertional dyspnea and cough as preludes to acute attacks of bronchial asthma. N Engl J Med 1975; 292: 555-559.
22. Fujimura M, Ogawa H, Yarui M, Matsuda T. Eosinophilic tracheobronchitis and airway hypersensitivity in chronic non-productive cough. Clin Exp Allergy 2000; 30: 41-47.
23. Brightling HM, Pavord ID. Eosinophilic bronchitis - what is it and why is it important? Clin Exp Allergy 2000; 30: 4-6.
24. Gibson PG, Zlatic K, Scott J, Sewell W, Woolley K, Saltos N. Chronic cough resembles asthma with IL-5 and granulocyte-macrophage colony-stimulating factor gene expression in bronchoalveolar cells. J Allergy Clin Immunol 1998; 101: 320-326.
25. Brightling CE, Ward R, Woltmann G, et al. Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma. Am J Respir Crit Care Med 2000; 162: 878-882.
26. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991; 325: 388-392.
27. Metso T, Kilpiö K, Björkstén F, Kiviranta K, Haahtela T. Detection and treatment of early asthma. Allergy 2000; 55: 505-509.
28. Rytilä P, Pelkonen AS, Metso T, Nikander K, Haahtela T, Turpeinen M. Induced sputum in children with newly diagnosed mild asthma: the effect of 6 months of treatment with budesonide or disodium cromoglycate. Allergy 2004; 59: 839-844.
29. Boushey HA, Sorkness CA, King TS, et al. Daily versus as needed corticosteroids for mild persistent asthma. N Engl J Med 2005; 352: 519-528.
30. O'Byrne PM. Daily inhaled corticosteroid treatment should be prescribed for mild persistent asthma. Am J Respir Crit Care Med 2005; 172: 410-412.
31. Boushey HA. Daily inhaled corticosteroid treatment should not be prescribed for mild persistent asthma. Am J Respir Crit Care Med 2005; 172: 412-414.
32. Haahtela T, Tamminen K, Malmberg LP, et al. Formoterol as needed with or without budesonide in patients with intermittent asthma and raised NO levels in exhaled air: a SOMA study. Eur Respir J 2006; 28: 748-755.
33. Puolijoki H, Lahdensuo A. Chronic cough as a risk indicator of broncho-pulmonary disease. Eur J Respir Dis 1987; 71: 77-85.